Inogen, Inc. is a medical technology company offering respiratory products for use in the homecare setting. The Company supports patient respiratory care by developing, manufacturing, and marketing portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its Inogen One and Inogen Rove systems concentrate the air around the patient to offer a source of supplemental oxygen with a battery and can be plugged into an outlet when at home, in a car, or in a public place with outlets available. Its Inogen One systems reduces patients' reliance on stationary concentrators and oxygen compressed gas tanks. Its Inogen Connect is a wireless connectivity platform for the Inogen One G4, Inogen One G5 and Rove 6 consisting of a front-end mobile application for use by long-term oxygen therapy users and a back-end database portal for use by homecare providers. It also offers Simeox, which is an airway clearance device.
BörsenkürzelINGN
Name des UnternehmensInogen Inc
IPO-datumFeb 14, 2014
CEOMr. Kevin R. M. Smith
Anzahl der mitarbeiter766
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 14
Addresse859 Ward Drive
StadtGOLETA
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl93111
Telefon18055620500
Websitehttps://www.inogen.com/
BörsenkürzelINGN
IPO-datumFeb 14, 2014
CEOMr. Kevin R. M. Smith
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten